Press releases
- Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- Gossamer Bio to Provide Updated Seralutinib TORREY Open-Label Extension Data at the American Thoracic Society 2024 International Conference
- Gossamer Bio Announces First Quarter 2024 Financial Results and Provides Business Update
- Gossamer Bio and Chiesi Group Announce Transformative Global Collaboration to Develop and Commercialize Seralutinib in PAH, PH-ILD & Other Indications
- Gossamer Bio Announces Publication of TORREY Phase 2 Results in the Lancet Respiratory Medicine
More ▼
Key statistics
On Tuesday, Gossamer Bio Inc (4GB:FRA) closed at 0.893, 106.86% above the 52 week low of 0.4317 set on Oct 25, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.954 |
---|---|
High | 0.955 |
Low | 0.893 |
Bid | -- |
Offer | -- |
Previous close | 0.8905 |
Average volume | 8.45k |
---|---|
Shares outstanding | 226.22m |
Free float | 219.54m |
P/E (TTM) | -- |
Market cap | 239.79m USD |
EPS (TTM) | -1.05 USD |
Data delayed at least 15 minutes, as of Jul 23 2024 14:29 BST.
More ▼